Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)Agnieszka Pluta, Agnieszka Wierzbowska, Kamil Brzozowski et al.|Leukemia & lymphoma/Leukemia and lymphoma|2019Cited by 3